This result is in agreement with the similar levels of circulating platelets in RT2-positive (HRG+/+ and HRG−/−) mice, regardless of genotype (Fig. 5A), and probably reflects the platelet activating properties of tumor cells. Here, HRG is linked to neoplasm.